Marcus Vinicius Pinto
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Marcus Vinicius Pinto has a total of 315 co-authors. Here are the top co-authors by number of shared publications:
- Christopher J. Klein
Department of Neurology, Mayo Clinic, Rochester, MN
10 shared publications - P. James Bonham Dyck
Department of Neurology Mayo Clinic Rochester Minnesota USA
10 shared publications - Teerin Liewluck
Department of Neurology, Mayo Clinic, Rochester, MN
9 shared publications - Márcia Waddington Cruz
Universidade Federal do Rio de Janeiro, Hospital Universitário Clementino Fraga Filho, Centro de Estudos em Paramiloidose Antônio Rodrigues de Mello, Rio de Janeiro RJ, Brazil
8 shared publications - Divyanshu Dubey
Department of Laboratory Medicine and Pathology Mayo Clinic Rochester Minnesota USA
6 shared publications - Michelle L. Mauermann
Department of Neurology, Mayo Clinic, Rochester, MN
6 shared publications
Latest Publications
- 1 December 2026
- Published by Wolters Kluwer Health in Neurology Education
- Vol. 5 (4)
How to Interpret Needle EMG Study
- 1 December 2026
- Published by Wolters Kluwer Health in Neurology Education
- Vol. 5 (4)
How to Interpret Needle EMG Study
- 22 September 2026
- Published by Wolters Kluwer Health in Neurology
- Vol. 107 (6) , e218501
Severe Parsonage-Turner Syndrome and Surgically Managed Traumatic Brachial Plexopathy
Background and ObjectivesLong-term motor recovery after absent motor-unit activation on EMG is incompletely characterized in Parsonage-Turner syndrome (PTS) and traumatic brachial plexopathy (TBP)....
- 22 September 2026
- Published by Wolters Kluwer Health in Neurology
- Vol. 107 (6) , e218501
Severe Parsonage-Turner Syndrome and Surgically Managed Traumatic Brachial Plexopathy
Background and ObjectivesLong-term motor recovery after absent motor-unit activation on EMG is incompletely characterized in Parsonage-Turner syndrome (PTS) and traumatic brachial plexopathy (TBP)....
- Open Access
- 1 September 2026
- Published by Wolters Kluwer Health in Neurology Education
- Vol. 5 (3) , e200341
Approach to Peripheral Neuropathies Leading to Hospital Admission
- 1 September 2026
- Published by Wolters Kluwer Health in Neurology Education
- Vol. 5 (3) , e200341
Open AccessApproach to Peripheral Neuropathies Leading to Hospital Admission
- 25 August 2026
- Published by Wolters Kluwer Health in Journal Of Clinical Neurophysiology
Neuromuscular Ultrasound and Electrophysiologic Correlation of Median Mononeuropathy at the Wrist in Symptomatic Hereditary Transthyretin Amyloidosis
Purpose: Hereditary transthyretin amyloidosis (ATTRv) is a progressive multisystem disease in which median mononeuropathy at the wrist (MNW) is common and often precedes systemic involvement. Nerve conduction studies (NCS) have historically been the gold standard for MNW, but neuromuscular ultrasound (NMUS) is complementary. The aim of this study was to compare NMUS with electrodiagnostic (EDX) testing for the diagnosis of MNW in patients with symptomatic ATTRv. Methods: A retrospective review was performed of patients 18 years and older with ATTRv confirmed by genetic testing who underwent both EDX testing and NMUS of the median nerve between 2019 and 2025. Demographic, NMUS, and EDX data were collected. Results: Data from 15 upper limbs in 10 patients were analyzed. Median nerve cross‐sectional area at the wrist was significantly greater than reference values ( P = 0.041). MNW was identified in 80% of wrists by NMUS and 100% by NCS, with no significant difference between modalities. Median nerve cross‐sectional area at the wrist did not significantly correlate with MNW severity determined by NCS ( r = −0.018; P = 0.941) or with any NCS parameters (all P > 0.080). Concurrent polyneuropathy was diagnosed in 60% of patients, but there was no association between polyneuropathy and MNW detection by either modality ( P > 0.197). Conclusions: NMUS and NCS demonstrate comparable diagnostic accuracy for MNW in ATTRv. Given its noninvasive nature and efficiency, NMUS may serve as an adjunct to classic EDX testing in this population.
- 25 August 2026
- Published by Wolters Kluwer Health in Journal Of Clinical Neurophysiology
Neuromuscular Ultrasound and Electrophysiologic Correlation of Median Mononeuropathy at the Wrist in Symptomatic Hereditary Transthyretin Amyloidosis
Purpose: Hereditary transthyretin amyloidosis (ATTRv) is a progressive multisystem disease in which median mononeuropathy at the wrist (MNW) is common and often precedes systemic involvement. Nerve conduction studies (NCS) have historically been the gold standard for MNW, but neuromuscular ultrasound (NMUS) is complementary. The aim of this study was to compare NMUS with electrodiagnostic (EDX) testing for the diagnosis of MNW in patients with symptomatic ATTRv. Methods: A retrospective review was performed of patients 18 years and older with ATTRv confirmed by genetic testing who underwent both EDX testing and NMUS of the median nerve between 2019 and 2025. Demographic, NMUS, and EDX data were collected. Results: Data from 15 upper limbs in 10 patients were analyzed. Median nerve cross‐sectional area at the wrist was significantly greater than reference values ( P = 0.041). MNW was identified in 80% of wrists by NMUS and 100% by NCS, with no significant difference between modalities. Median nerve cross‐sectional area at the wrist did not significantly correlate with MNW severity determined by NCS ( r = −0.018; P = 0.941) or with any NCS parameters (all P > 0.080). Concurrent polyneuropathy was diagnosed in 60% of patients, but there was no association between polyneuropathy and MNW detection by either modality ( P > 0.197). Conclusions: NMUS and NCS demonstrate comparable diagnostic accuracy for MNW in ATTRv. Given its noninvasive nature and efficiency, NMUS may serve as an adjunct to classic EDX testing in this population.
- 13 July 2026
- Published by Wolters Kluwer Health in Neurology
- Vol. 107 (3) , e218304
Association of Plasma Neurofilament Light Chain With Diagnostic Classification in a Neuromuscular Referral Cohort: A Cross-Sectional Study.
Plasma neurofilament light chain (pNfL) is a blood-based biomarker of axonal injury elevated in several neuromuscular disorders. While previous studies have compared individual diseases with healthy controls, less is known about how pNfL performs across clinically relevant neuromuscular presentations encountered in subspecialty practice, particularly in distinguishing active from inactive neuropathies. We evaluated whether abnormal age-adjusted pNfL concentrations are associated with clinically relevant diagnostic categories and whether pNfL discriminates between active and inactive neuropathies. We conducted a cross-sectional study of patients evaluated by neuromuscular specialists at Mayo Clinic (Rochester, MN) between April 2022 and April 2024, in whom pNfL was ordered as part of routine clinical care. Diagnoses were assigned to prespecified categories by consensus review, including motor neuron disease (MND), active neuropathy, inactive neuropathy, and structural etiologies. Clinically active neuropathy was defined using prespecified, diagnosis-specific operational criteria incorporating treatment status, clinical relapse or progression, time from symptom onset, and pathologic evidence of inflammation. Abnormal pNfL was defined using previously established age-adjusted 97.5th percentile reference limits. Multinomial logistic regression evaluated associations between abnormal pNfL and diagnostic category, adjusting for neuropathy impairment score and symptom duration. Receiver operating characteristic (ROC) analyses assessed discrimination between prespecified groups. Among 306 patients (mean age 62.2 years, 41.5% female), 179 (58.5%) had MND, 28 (9.1%) active neuropathy, 75 (12.1%) inactive neuropathy, and 24 (7.8%) structural etiologies. Median pNfL concentrations differed across diagnostic groups (p < 0.0001) and were highest in MND and active neuropathy. After adjustment, abnormal pNfL was associated with a higher relative likelihood of classification as MND (relative risk ratio [RRR] 18.47, 95% CI 8.77-38.86) and active neuropathy (RRR 7.30, 95% CI 2.50-21.34) compared with inactive neuropathies. No association was observed with structural etiologies. Discrimination between active and inactive neuropathy was moderate (area under the curve [AUC] 0.79, 95% CI 0.70-0.88), and discrimination for MND vs all other diagnoses was good (AUC 0.85, 95% CI 0.80-0.90). In this cross-sectional cohort, abnormal age-adjusted pNfL concentrations were more frequently observed in diagnostic categories characterized by clinically active axonal injury than in inactive neuropathies and structural conditions. These findings suggest a potential role for pNfL as an adjunctive tool in neuromuscular diagnostic evaluation. Interpretation is limited by the cross-sectional design and convenience sampling. This study provides Class II evidence that abnormal age-adjusted pNfL distinguishes active neuropathies from inactive neuropathies with moderate diagnostic accuracy.
- 13 July 2026
- Published by Wolters Kluwer Health in Neurology
- Vol. 107 (3) , e218304
Association of Plasma Neurofilament Light Chain With Diagnostic Classification in a Neuromuscular Referral Cohort: A Cross-Sectional Study.
Plasma neurofilament light chain (pNfL) is a blood-based biomarker of axonal injury elevated in several neuromuscular disorders. While previous studies have compared individual diseases with healthy controls, less is known about how pNfL performs across clinically relevant neuromuscular presentations encountered in subspecialty practice, particularly in distinguishing active from inactive neuropathies. We evaluated whether abnormal age-adjusted pNfL concentrations are associated with clinically relevant diagnostic categories and whether pNfL discriminates between active and inactive neuropathies. We conducted a cross-sectional study of patients evaluated by neuromuscular specialists at Mayo Clinic (Rochester, MN) between April 2022 and April 2024, in whom pNfL was ordered as part of routine clinical care. Diagnoses were assigned to prespecified categories by consensus review, including motor neuron disease (MND), active neuropathy, inactive neuropathy, and structural etiologies. Clinically active neuropathy was defined using prespecified, diagnosis-specific operational criteria incorporating treatment status, clinical relapse or progression, time from symptom onset, and pathologic evidence of inflammation. Abnormal pNfL was defined using previously established age-adjusted 97.5th percentile reference limits. Multinomial logistic regression evaluated associations between abnormal pNfL and diagnostic category, adjusting for neuropathy impairment score and symptom duration. Receiver operating characteristic (ROC) analyses assessed discrimination between prespecified groups. Among 306 patients (mean age 62.2 years, 41.5% female), 179 (58.5%) had MND, 28 (9.1%) active neuropathy, 75 (12.1%) inactive neuropathy, and 24 (7.8%) structural etiologies. Median pNfL concentrations differed across diagnostic groups (p < 0.0001) and were highest in MND and active neuropathy. After adjustment, abnormal pNfL was associated with a higher relative likelihood of classification as MND (relative risk ratio [RRR] 18.47, 95% CI 8.77-38.86) and active neuropathy (RRR 7.30, 95% CI 2.50-21.34) compared with inactive neuropathies. No association was observed with structural etiologies. Discrimination between active and inactive neuropathy was moderate (area under the curve [AUC] 0.79, 95% CI 0.70-0.88), and discrimination for MND vs all other diagnoses was good (AUC 0.85, 95% CI 0.80-0.90). In this cross-sectional cohort, abnormal age-adjusted pNfL concentrations were more frequently observed in diagnostic categories characterized by clinically active axonal injury than in inactive neuropathies and structural conditions. These findings suggest a potential role for pNfL as an adjunctive tool in neuromuscular diagnostic evaluation. Interpretation is limited by the cross-sectional design and convenience sampling. This study provides Class II evidence that abnormal age-adjusted pNfL distinguishes active neuropathies from inactive neuropathies with moderate diagnostic accuracy.
- 26 June 2026
- Published by Springer Nature in Neurological Sciences
- Vol. 47 (7)
Hereditary gelsolin amyloidosis in Brazil: case report and brief review of the literature
- 26 June 2026
- Published by Springer Nature in Neurological Sciences
- Vol. 47 (7)
Hereditary gelsolin amyloidosis in Brazil: case report and brief review of the literature
- 9 June 2026
- Published by Wolters Kluwer Health in Neurology
- Vol. 106 (11) , e218033
Sensitivity of Nerve and Skin Biopsy and Fat Aspirate for Amyloid in Symptomatic Hereditary ATTR Amyloidosis With Peripheral Neuropathy
ObjectivesThe aim of this study was to compare the sensitivity of nerve biopsy, fat aspirate, and skin biopsy in detecting amyloid in symptomatic hereditary transthyretin amyloidosis with periphera...
- 9 June 2026
- Published by Wolters Kluwer Health in Neurology
- Vol. 106 (11) , e218033
Sensitivity of Nerve and Skin Biopsy and Fat Aspirate for Amyloid in Symptomatic Hereditary ATTR Amyloidosis With Peripheral Neuropathy
ObjectivesThe aim of this study was to compare the sensitivity of nerve biopsy, fat aspirate, and skin biopsy in detecting amyloid in symptomatic hereditary transthyretin amyloidosis with periphera...
- 28 April 2026
- Published by BMJ in Practical Neurology
Peripheral nerves can serve as a sanctuary for lymphoma
- 28 April 2026
- Published by BMJ in Practical Neurology
Peripheral nerves can serve as a sanctuary for lymphoma
- Open Access
- 1 December 2025
- Published by Wolters Kluwer Health in Neurology Education
- Vol. 4 (4) , e200275
How to Interpret a Nerve Conduction Study
- 1 December 2025
- Published by Wolters Kluwer Health in Neurology Education
- Vol. 4 (4) , e200275
Open AccessHow to Interpret a Nerve Conduction Study
- 9 October 2025
- Published by BMJ in Practical Neurology
- Vol. 26 (3) , 272-275
Superficial siderosis in Marfan syndrome
A 49-year-old woman presented with a dorsal column-predominant sensory myelopathy secondary to superficial siderosis. She had Marfan syndrome and was found to have dural ectasia. Superficial siderosis results from subpial haemosiderin deposition due to chronic subarachnoid space bleeding, often from a dural pathology, such as a tear. Dural ectasia is common in Marfan syndrome, but superficial siderosis is not. Gait ataxia, often with hearing impairment, is a common clinical presentation of superficial siderosis. Patients may develop myelopathy, here being a pure sensory myelopathy with predominant dorsal column deficit. Meningeal diverticulae and superficial siderosis are both associated with cerebrospinal fluid (CSF) leaks. This patient had dural ectasia and meningeal diverticulae, but the CT myelogram found no CSF leak. Superficial siderosis should be considered in patients with sensory myelopathy. Lumbosacral dural ectasia, or less likely CSF leak, can cause superficial siderosis in people with Marfan syndrome.
- 9 October 2025
- Published by BMJ in Practical Neurology
- Vol. 26 (3) , 272-275
Superficial siderosis in Marfan syndrome
A 49-year-old woman presented with a dorsal column-predominant sensory myelopathy secondary to superficial siderosis. She had Marfan syndrome and was found to have dural ectasia. Superficial siderosis results from subpial haemosiderin deposition due to chronic subarachnoid space bleeding, often from a dural pathology, such as a tear. Dural ectasia is common in Marfan syndrome, but superficial siderosis is not. Gait ataxia, often with hearing impairment, is a common clinical presentation of superficial siderosis. Patients may develop myelopathy, here being a pure sensory myelopathy with predominant dorsal column deficit. Meningeal diverticulae and superficial siderosis are both associated with cerebrospinal fluid (CSF) leaks. This patient had dural ectasia and meningeal diverticulae, but the CT myelogram found no CSF leak. Superficial siderosis should be considered in patients with sensory myelopathy. Lumbosacral dural ectasia, or less likely CSF leak, can cause superficial siderosis in people with Marfan syndrome.